MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval - 25 October 2022 10:17

GENEVA, Oct. 25, 2022 /PRNewswire-AsiaNet/ -- Following our communication last week "MedAlliance to be acquired by Cordis", MedAlliance is pleased to make the following announcement: Photo - https://mma.prnewswire.com/media/1928464/MedAlliance_Image.jpg Logo - https://mma.prnewswire.com...

  T-cells treated by Turn Biotechnologies show increased cancer-... - 25 October 2022 02:30

MOUNTAIN VIEW, Calif., Oct. 25, 2022 /PRNewswire-AsiaNet/ -- - Preclinical data showing how ERA(TM), eTurna(TM) technologies turbocharge T-cell therapies presented at New Frontiers of RNA Nanotherapeutics meeting today - ERA(TM) boosts CAR T-cell efficacy by overcoming T-cell exhaustion that inhibits cance...

   deCODE genetics publishes multiomics study of nonalcoholic fa... - 25 October 2022 02:00

REYKJAVIK, Iceland Oct 24th, 2022 /PRNewswire-AsiaNet/ Scientists at deCODE genetics, a subsidiary of Amgen, publish today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were identified, including rar...

  SIRONA completes enrollment - A leap in the DCB treatment of f... - 22 October 2022 00:06

TAMPA, Fla., Oct. 21, 2022 /PRNewswire-AsiaNet/ -- Concept Medical Inc. [https://www.conceptmedical.com/] announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA [https://ww...

  On World Osteoporosis Day, take five steps to better bone health - 20 October 2022 22:00

NYON, Switzerland, Oct. 20, 2022, /PRNewswire-AsiaNet/-- Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention. Osteoporosis is a bone disease that affects some...

  Alfasigma Acquires The Entire Share Capital Of Sofar, An Itali... - 20 October 2022 17:45

POMEZIA, Italy, Oct. 20, 2022 /PRNewswire-AsiaNet/ -- Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was scheduled for completion in October 2022, was succes...

  Consumer Healthcare Products (CHP) Australia Streamlines Conte... - 20 October 2022 10:05

SYDNEY, Oct. 20, 2022 /PRNewswire-AsiaNet/ -- *CHP's AdCheck independent advertising advisory service creates content management and communication efficiencies for members Veeva Systems(https://www.veeva.com/) (NYSE: VEEV) today announced that AdCheck(https://www.chpaustralia.com.au/AdChec...

  U.S. FDA Grants Emergency Use Authorization for Novavax COVID-... - 20 October 2022 03:51

GAITHERSBURG, Md., Oct. 20, 2022 /PRNewswire-AsiaNet/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received em...

  MedAlliance to be Acquired by Cordis - 19 October 2022 10:00

GENEVA, Oct. 19, 2022 /PRNewswire-AsiaNet/ -- Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of $200M, regulatory achievement mileston...

  Alphyn Biologics Announces Enrollment Passes Halfway Point in ... - 18 October 2022 22:30

ANNAPOLIS, Md., Oct. 18, 2022 /PRNewswire-Asianet/ -- --Study evaluates AB-101a for patients with and without concurrent bacterial infection Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3680049-1&h=958198912&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-...